✦ LIBER ✦

Patient-reported outcomes after cytotoxic chemotherapy in metastatic castration-resistant prostate cancer: A systematic review

✍ Scribed by Giuseppe Colloca; Antonella Venturino; Franco Checcaglini

Book ID: 116395472
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 176 KB
Volume: 36
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2010.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN22 Immunotherapy With Sipuleucel-T (A

PCN22 Immunotherapy With Sipuleucel-T (APC8015) in Patients With Metastatic Castration-Refractory Prostate Cancer (mCRPC): A Systematic Review and Meta-Analysis

✍ T.E.A. Botrel; O.A.C. Clark; A.C.L. Pompeo; F.F.H. Bretas; M.V. Sadi; U. Ferreir 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Association of Rash With Outcomes in a R

Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer

✍ Mark T. Fleming; Guru Sonpavde; Michael Kolodziej; Sanjay Awasthi; Thomas E. Hut 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 434 KB

705 ABIRATERONE ACETATE PLUS LOW-DOSE PR

705 ABIRATERONE ACETATE PLUS LOW-DOSE PREDNISONE HAS A FAVORABLE SAFETY PROFILE, IMPROVES SURVIVAL AND PRODUCES PSA AND RADIOGRAPHIC RESPONSES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER DOCETAXEL-BASED CHEMOTHERAPY: RESULTS FROM COU-AA-301, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY

✍ Saad, Fred; de Bono, Johann S.; Haqq, Christopher M.; Logothetis, Christopher J. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB